S. Korea Group Urges Harder Look At IPA-Containing Painkillers
This article was originally published in PharmAsia News
Executive Summary
South Korea should take greater steps to ensure the safety of painkillers with isopropylantipyrine, according to the Korean Society for Pharmacoepidemiology and Risk Management. The group said the the drugs caused at least six cases of side effects as far back as 2002, and it counted six more recent cases of side effects that should have highlighted the risks. The Korean Food and Drug Administration identified three more cases in early December. IPA-containing painkillers are made in South Korea by Chong Kun Dang, Samjin Pharm, Dong-A Pharmaceutical and Bayer Korea. Chief side effects are cardiovascular disorders, spasms and unconsciousness. (Click here for more